BARCELONA, Spain — Almirall has expanded its collaboration with the Barcelona Supercomputing Center to accelerate research and development in medical dermatology through the use of artificial intelligence and high-performance computing.
The new framework agreement builds on an existing partnership between the two organizations and aims to identify new opportunities in the discovery of treatments for skin diseases. Company officials said the collaboration is part of Almirall’s broader strategy to integrate advanced technologies into its research pipeline.
As part of the agreement, Almirall will join the Barcelona Supercomputing Center’s “BSC Connects” program, designed to foster collaboration between scientific institutions and industry partners. The program provides access to specialized training, advanced computing tools, and support for developing joint research projects throughout 2026.
The partnership is expected to strengthen Almirall’s ability to incorporate technologies such as genomics, digital modeling, and drug design into its work, while enabling researchers from both organizations to collaborate more closely on dermatological challenges.
“Our passion for medical dermatology drives us to constantly seek innovative solutions that can make a real difference in patients’ lives,” said Dr. Karl Ziegelbauer, chief scientific officer at Almirall. “Strengthening our collaboration with a world-class institution like BSC is a crucial step in our journey. By combining their expertise in supercomputing and AI with our deep understanding of dermatology, we are creating a powerful synergy to accelerate the development of the next generation of skin treatments. This initiative aligns perfectly with our vision of being at the forefront of science and technology to transform patients’ lives and represents a key pillar in accelerating our ability to discover and develop innovative therapies.”
Officials said the collaboration will also support the identification of high-impact technologies and expand opportunities for joint research across multiple scientific areas.
“This agreement with Almirall, within the framework of the BSC Connects program, is an example of how supercomputing and artificial intelligence can be placed at the service of industry to generate a real impact on people’s health,” said Mateo Valero, director of the Barcelona Supercomputing Center. “BSC and Almirall share a vision of collaboration rooted in a broader research partnership and the use of technology as a driver of innovation. Together we can contribute to advancing the field of medical dermatology by providing tools and capabilities that make a real difference.”
The companies said the expanded partnership reflects a continued push toward using advanced computing and collaborative research models to speed the development of new dermatology treatments.
